These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 22580623)

  • 21. Expanded application of selective neck dissection with regard to nodal status.
    Pellitteri PK; Robbins KT; Neuman T
    Head Neck; 1997 Jul; 19(4):260-5. PubMed ID: 9213103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients.
    Suwinski R; Sowa A; Rutkowski T; Wydmanski J; Tarnawski R; Maciejewski B
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):399-412. PubMed ID: 12738315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns-of-failure guided biological target volume definition for head and neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions.
    Mohamed ASR; Cardenas CE; Garden AS; Awan MJ; Rock CD; Westergaard SA; Brandon Gunn G; Belal AM; El-Gowily AG; Lai SY; Rosenthal DI; Fuller CD; Aristophanous M
    Radiother Oncol; 2017 Aug; 124(2):248-255. PubMed ID: 28774596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positron emission tomography-computed tomography surveillance for the node-positive neck after chemoradiotherapy.
    Rabalais AG; Walvekar R; Nuss D; McWhorter A; Wood C; Fields R; Mercante DE; Pou AM
    Laryngoscope; 2009 Jun; 119(6):1120-4. PubMed ID: 19358193
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    van den Bosch S; Doornaert PAH; Dijkema T; Zwijnenburg EM; Verhoef LCG; Hoeben BAW; Kasperts N; Smid EJ; Terhaard CHJ; Kaanders JHAM
    Radiother Oncol; 2020 Jan; 142():107-114. PubMed ID: 31439447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
    Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
    Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule.
    Numico G; Russi EG; Vitiello R; Sorrentino R; Colantonio I; Cipolat M; Taglianti RV; Pelissero A; Fea E; Granetto C; Di Costanzo G; Gasco M; Garrone O; Occelli M; Merlano M
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):731-7. PubMed ID: 17011449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of preoperative 18F-FDG PET/CT for primary head and neck squamous cell carcinoma.
    Joo YH; Yoo IeR; Cho KJ; Park JO; Nam IC; Kim CS; Kim MS
    Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1685-91. PubMed ID: 23949547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disease Control and Late Toxicity in Adaptive Dose Painting by Numbers Versus Nonadaptive Radiation Therapy for Head and Neck Cancer: A Randomized Controlled Phase 2 Trial.
    De Bruycker A; De Neve W; Daisne JF; Vercauteren T; De Gersem W; Olteanu L; Berwouts D; Deheneffe S; Madani I; Goethals I; Duprez F
    Int J Radiat Oncol Biol Phys; 2024 Oct; 120(2):516-527. PubMed ID: 38387811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Origin of tumor recurrence after intensity modulated radiation therapy for oropharyngeal squamous cell carcinoma.
    Raktoe SA; Dehnad H; Raaijmakers CP; Braunius W; Terhaard CH
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):136-41. PubMed ID: 22541959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive surgical margins in neck dissection specimens in patients with head and neck squamous cell carcinoma and the effect of radiotherapy.
    Smeele LE; Leemans CR; Langendijk JA; Tiwari R; Slotman BJ; van Der Waal I; Snow GB
    Head Neck; 2000 Sep; 22(6):559-63. PubMed ID: 10941156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Locoregional recurrences after post-operative volumetric modulated arc radiotherapy (VMAT) in oral cavity cancers in a resource constrained setting: experience and lessons learned.
    Chakraborty S; Patil VM; Babu S; Muttath G; Thiagarajan SK
    Br J Radiol; 2015 Apr; 88(1048):20140795. PubMed ID: 25645107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of [
    Pisani C; Vigna L; Mastroleo F; Loi G; Amisano V; Masini L; Deantonio L; Aluffi Valletti P; Sacchetti G; Krengli M
    Radiat Oncol; 2021 Mar; 16(1):57. PubMed ID: 33743759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elective neck dissection during salvage surgery for locally recurrent head and neck squamous cell carcinoma after radiotherapy with elective nodal irradiation.
    Dagan R; Morris CG; Kirwan JM; Werning JW; Vaysberg M; Amdur RJ; Mendenhall WM
    Laryngoscope; 2010 May; 120(5):945-52. PubMed ID: 20422688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open source deformable image registration system for treatment planning and recurrence CT scans : Validation in the head and neck region.
    Zukauskaite R; Brink C; Hansen CR; Bertelsen A; Johansen J; Grau C; Eriksen JG
    Strahlenther Onkol; 2016 Aug; 192(8):545-51. PubMed ID: 27323754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of Recurrence in Electively Irradiated Lymph Node Regions After Definitive Accelerated Intensity Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma.
    van den Bosch S; Dijkema T; Verhoef LC; Zwijnenburg EM; Janssens GO; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):766-74. PubMed ID: 26972649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical management of local and regional recurrent head and neck squamous cell carcinoma.
    Watson JC; Ridge JA
    Curr Opin Oncol; 1998 May; 10(3):207-12. PubMed ID: 9619356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicentric in silico ROCOCO trial.
    Eekers DBP; Roelofs E; Jelen U; Kirk M; Granzier M; Ammazzalorso F; Ahn PH; Janssens GORJ; Hoebers FJP; Friedmann T; Solberg T; Walsh S; Troost EGC; Kaanders JHAM; Lambin P
    Radiother Oncol; 2016 Dec; 121(3):387-394. PubMed ID: 27639891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between pretreatment FDG-PET biological target volume and location of T-site failure after definitive radiation therapy for head and neck cancers.
    Sand HM; Brunø AH; Andersen LJ; Carl J
    Acta Oncol; 2015; 54(9):1682-5. PubMed ID: 26398889
    [No Abstract]   [Full Text] [Related]  

  • 40. Methodology for analysis and reporting patterns of failure in the Era of IMRT: head and neck cancer applications.
    Mohamed AS; Rosenthal DI; Awan MJ; Garden AS; Kocak-Uzel E; Belal AM; El-Gowily AG; Phan J; Beadle BM; Gunn GB; Fuller CD
    Radiat Oncol; 2016 Jul; 11(1):95. PubMed ID: 27460585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.